XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of RSU Activity

The following is a summary of RSU activity under our 2014 EIP and Inducement Plan:

 

 

RSUs

 

 

 

Shares

 

 

Weighted
Average
Grant Date
Fair Value

 

Balance as of December 31, 2022

 

 

6,708,608

 

 

$

10.61

 

Granted

 

 

5,635,916

 

 

$

3.57

 

Forfeited

 

 

(2,388,808

)

 

$

7.91

 

Vested

 

 

(3,688,003

)

 

$

8.89

 

Balance as of December 31, 2023

 

 

6,267,713

 

 

$

6.32

 

Summary of Stock Option Activity

The following is a summary of stock option activity under our 2014 EIP and Inducement Plan:

 

 

Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average
Remaining
Contractual
Term (Years)

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Balance as of December 31, 2022

 

 

10,645,555

 

 

$

16.88

 

 

 

6.4

 

 

$

42

 

Granted

 

 

4,693,897

 

 

 

3.64

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(4,619,801

)

 

 

15.60

 

 

 

 

 

 

 

Balance as of December 31, 2023

 

 

10,719,651

 

 

$

11.63

 

 

 

6.5

 

 

$

 

Vested and expected to vest as of
   December 31, 2023

 

 

10,719,651

 

 

$

11.63

 

 

 

6.5

 

 

$

 

Exercisable as of December 31, 2023

 

 

6,389,752

 

 

$

15.40

 

 

 

5.1

 

 

$

 

Summary of Options Estimated with Weighted Average

The fair value of each option issued was estimated at the date of grant using the Black-Scholes valuation model. The following table summarizes the weighted-average assumptions used as inputs to the Black-Scholes model and resulting weighted-average grant date fair values of stock options granted during the periods indicated:

 

 

Year ended December 31,

 

 

 

2023

 

 

2022

 

Assumptions:

 

 

 

 

 

 

Expected term (years)

 

 

5.80

 

 

 

6.0

 

Expected volatility

 

 

83.9

%

 

 

73.2

%

Risk-free interest rate

 

 

4.2

%

 

 

2.1

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

Fair Value:

 

 

 

 

 

 

Weighted-average estimated grant date fair value per share

 

$

2.62

 

 

$

5.88

 

Options granted

 

 

4,693,897

 

 

 

3,615,971

 

Total estimated grant date fair value

 

$

12,298,010

 

 

$

21,261,909

 

Schedule of Common Stock Reserved for Future Issuance Under Equity Incentive Plans

The following shares of common stock were reserved for future issuance under our equity incentive plans as of December 31, 2023:

 

 

Total Shares Reserved

 

2014 Equity Incentive Plan

 

 

20,326,356

 

2018 Inducement Plan

 

 

4,773,147

 

2014 Employee Stock Purchase Plan

 

 

10,593

 

Total reserved shares of common stock

 

 

25,110,096

 

Schedule of Stock-based Compensation Related to Stock Awards

The following is a summary of stock-based compensation expense for the periods presented:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

 

(in thousands)

 

Research and development

 

$

26,529

 

 

$

31,363

 

General and administrative

 

 

18,857

 

 

 

22,475

 

Total stock-based compensation expense

 

$

45,386

 

 

$

53,838